Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FR9I
|
|||
| Drug Name |
Aryl oxyanilide derivative 3
|
|||
| Synonyms |
PMID27607364-Compound-9
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
TAISHO PHARMACEUTICAL CO., LTD. NIHON, NOHYAKU CO., LTD. NAKAZATO, Atsuro OKUBO, Taketoshi NAKAMURA, Toshio CHAKI, Shigeyuki TOMISAWA, Kazuyuki NAGAMINE, Masashi YAMAMOTO, Kenji HARADA, Koichiro YOSHIDA, Masanor
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H22FNO4
|
|||
| Canonical SMILES |
CC(=O)N(CC1=C(C=CC(=C1)OC)OC)C2=C(C=CC(=C2)F)OC3=CC=CC=C3
|
|||
| InChI |
1S/C23H22FNO4/c1-16(26)25(15-17-13-20(27-2)10-12-22(17)28-3)21-14-18(24)9-11-23(21)29-19-7-5-4-6-8-19/h4-14H,15H2,1-3H3
|
|||
| InChIKey |
DCRZYADKQRHHSF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 220551-92-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
| Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| HTLV-I infection | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.